

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | deoxyribonucleoside monophosphate metabolic process (GO:0009162) | 5.07151851 |
| 2 | synaptic vesicle exocytosis (GO:0016079) | 4.93177652 |
| 3 | regulation of short-term neuronal synaptic plasticity (GO:0048172) | 4.75125939 |
| 4 | synaptic vesicle maturation (GO:0016188) | 4.71089639 |
| 5 | positive regulation of calcium ion-dependent exocytosis (GO:0045956) | 4.68106498 |
| 6 | locomotory exploration behavior (GO:0035641) | 4.66108059 |
| 7 | vocalization behavior (GO:0071625) | 4.62504321 |
| 8 | lipopolysaccharide biosynthetic process (GO:0009103) | 4.58425093 |
| 9 | valine metabolic process (GO:0006573) | 4.56899790 |
| 10 | neuron cell-cell adhesion (GO:0007158) | 4.51234496 |
| 11 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 4.31400613 |
| 12 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 4.31400613 |
| 13 | modulation by symbiont of host immune response (GO:0052553) | 4.31400613 |
| 14 | positive regulation by symbiont of host defense response (GO:0052509) | 4.31400613 |
| 15 | modulation by symbiont of host defense response (GO:0052031) | 4.31400613 |
| 16 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 4.31400613 |
| 17 | positive regulation of excitatory postsynaptic membrane potential (GO:2000463) | 4.30910354 |
| 18 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor act | 4.30163890 |
| 19 | negative regulation of erythrocyte differentiation (GO:0045647) | 4.28571325 |
| 20 | protein localization to synapse (GO:0035418) | 4.25927182 |
| 21 | NIK/NF-kappaB signaling (GO:0038061) | 4.24641423 |
| 22 | heme biosynthetic process (GO:0006783) | 4.20882964 |
| 23 | layer formation in cerebral cortex (GO:0021819) | 4.20386527 |
| 24 | glutamate secretion (GO:0014047) | 4.19511010 |
| 25 | regulation of interferon-beta biosynthetic process (GO:0045357) | 4.14029182 |
| 26 | regulation of synaptic vesicle exocytosis (GO:2000300) | 4.05228029 |
| 27 | neuronal action potential propagation (GO:0019227) | 4.04724918 |
| 28 | regulation of synapse structural plasticity (GO:0051823) | 4.04110339 |
| 29 | negative regulation of B cell apoptotic process (GO:0002903) | 4.01148715 |
| 30 | response to host immune response (GO:0052572) | 4.00549277 |
| 31 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 4.00549277 |
| 32 | lipopolysaccharide metabolic process (GO:0008653) | 3.99236150 |
| 33 | regulation of glutamate receptor signaling pathway (GO:1900449) | 3.98168685 |
| 34 | heme metabolic process (GO:0042168) | 3.94338354 |
| 35 | chaperone mediated protein folding requiring cofactor (GO:0051085) | 3.90787572 |
| 36 | response to host (GO:0075136) | 3.78169668 |
| 37 | response to host defenses (GO:0052200) | 3.78169668 |
| 38 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 3.78169668 |
| 39 | exploration behavior (GO:0035640) | 3.76939463 |
| 40 | ionotropic glutamate receptor signaling pathway (GO:0035235) | 3.74096878 |
| 41 | dendritic spine morphogenesis (GO:0060997) | 3.73265988 |
| 42 | neurotransmitter secretion (GO:0007269) | 3.66842777 |
| 43 | regulation of synaptic vesicle transport (GO:1902803) | 3.63392408 |
| 44 | positive regulation of B cell differentiation (GO:0045579) | 3.58500479 |
| 45 | immunoglobulin mediated immune response (GO:0016064) | 3.58308394 |
| 46 | cerebellar Purkinje cell layer development (GO:0021680) | 3.57943590 |
| 47 | regulation of neuronal synaptic plasticity (GO:0048168) | 3.57318398 |
| 48 | positive regulation of potassium ion transmembrane transporter activity (GO:1901018) | 3.56235924 |
| 49 | regulation of long-term neuronal synaptic plasticity (GO:0048169) | 3.55890421 |
| 50 | neuron recognition (GO:0008038) | 3.53068436 |
| 51 | neuromuscular process controlling posture (GO:0050884) | 3.46159479 |
| 52 | cellular potassium ion homeostasis (GO:0030007) | 3.44546390 |
| 53 | gamma-aminobutyric acid transport (GO:0015812) | 3.43126931 |
| 54 | glutamate receptor signaling pathway (GO:0007215) | 3.42387712 |
| 55 | regulation of N-methyl-D-aspartate selective glutamate receptor activity (GO:2000310) | 3.39553803 |
| 56 | pentose-phosphate shunt (GO:0006098) | 3.38898909 |
| 57 | pyrimidine deoxyribonucleotide catabolic process (GO:0009223) | 3.38126833 |
| 58 | protoporphyrinogen IX biosynthetic process (GO:0006782) | 3.37319787 |
| 59 | protoporphyrinogen IX metabolic process (GO:0046501) | 3.36056311 |
| 60 | dendrite morphogenesis (GO:0048813) | 3.33558190 |
| 61 | neuron-neuron synaptic transmission (GO:0007270) | 3.30723095 |
| 62 | striatum development (GO:0021756) | 3.30485216 |
| 63 | regulation of excitatory postsynaptic membrane potential (GO:0060079) | 3.24596264 |
| 64 | synaptic transmission, glutamatergic (GO:0035249) | 3.23601398 |
| 65 | neurotransmitter-gated ion channel clustering (GO:0072578) | 3.22876924 |
| 66 | transmission of nerve impulse (GO:0019226) | 3.22828392 |
| 67 | gamma-aminobutyric acid signaling pathway (GO:0007214) | 3.22006469 |
| 68 | axonal fasciculation (GO:0007413) | 3.21249037 |
| 69 | porphyrin-containing compound biosynthetic process (GO:0006779) | 3.20322274 |
| 70 | protein maturation by protein folding (GO:0022417) | 3.20139777 |
| 71 | neurotransmitter transport (GO:0006836) | 3.18786752 |
| 72 | negative regulation of synaptic transmission, GABAergic (GO:0032229) | 3.18476035 |
| 73 | Golgi transport vesicle coating (GO:0048200) | 3.18153569 |
| 74 | COPI coating of Golgi vesicle (GO:0048205) | 3.18153569 |
| 75 | regulation of dendritic spine morphogenesis (GO:0061001) | 3.17659991 |
| 76 | negative regulation of release of cytochrome c from mitochondria (GO:0090201) | 3.16868561 |
| 77 | positive regulation of prostaglandin secretion (GO:0032308) | 3.16735049 |
| 78 | synaptic vesicle endocytosis (GO:0048488) | 3.15881519 |
| 79 | behavioral response to cocaine (GO:0048148) | 3.14097518 |
| 80 | sodium ion export (GO:0071436) | 3.13649265 |
| 81 | 2-oxoglutarate metabolic process (GO:0006103) | 3.12490593 |
| 82 | regulation of postsynaptic membrane potential (GO:0060078) | 3.12443861 |
| 83 | positive regulation of synaptic transmission, dopaminergic (GO:0032226) | 3.10713429 |
| 84 | porphyrin-containing compound metabolic process (GO:0006778) | 3.10540273 |
| 85 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 3.10502114 |
| 86 | positive regulation of monocyte chemotaxis (GO:0090026) | 3.09208834 |
| 87 | central nervous system myelination (GO:0022010) | 3.08166353 |
| 88 | axon ensheathment in central nervous system (GO:0032291) | 3.08166353 |
| 89 | daunorubicin metabolic process (GO:0044597) | 3.08057828 |
| 90 | polyketide metabolic process (GO:0030638) | 3.08057828 |
| 91 | doxorubicin metabolic process (GO:0044598) | 3.08057828 |
| 92 | regulation of metalloenzyme activity (GO:0048552) | 3.07374483 |
| 93 | activation of protein kinase A activity (GO:0034199) | 3.04030540 |
| 94 | response to histamine (GO:0034776) | 3.03895926 |
| 95 | negative regulation of myeloid cell apoptotic process (GO:0033033) | 3.03526966 |
| 96 | antigen processing and presentation of endogenous antigen (GO:0019883) | 3.03072819 |
| 97 | regulation of inhibitory postsynaptic membrane potential (GO:0060080) | 3.02604155 |
| 98 | synaptic vesicle docking involved in exocytosis (GO:0016081) | 3.00550693 |
| 99 | positive regulation of dendritic spine development (GO:0060999) | 2.99387449 |
| 100 | neuromuscular process controlling balance (GO:0050885) | 2.99141388 |
| 101 | membrane hyperpolarization (GO:0060081) | 2.98835129 |
| 102 | proline transport (GO:0015824) | 2.97830144 |
| 103 | regulation of voltage-gated calcium channel activity (GO:1901385) | 2.97233643 |
| 104 | negative regulation of lymphocyte apoptotic process (GO:0070229) | 2.96577360 |
| 105 | cell communication by electrical coupling involved in cardiac conduction (GO:0086064) | 2.96105493 |
| 106 | positive regulation of membrane potential (GO:0045838) | 2.95451804 |
| 107 | regulation of neurotransmitter levels (GO:0001505) | 2.94043232 |
| 108 | long-term memory (GO:0007616) | 2.93826052 |
| 109 | pyrimidine nucleobase catabolic process (GO:0006208) | 2.93347784 |
| 110 | NADPH regeneration (GO:0006740) | 2.93083313 |
| 111 | positive regulation of mitochondrial calcium ion concentration (GO:0051561) | 2.93015013 |
| 112 | positive regulation of synapse maturation (GO:0090129) | 2.91663881 |
| 113 | positive regulation of T cell migration (GO:2000406) | 2.91012999 |
| 114 | L-amino acid import (GO:0043092) | 2.90791624 |
| 115 | mitochondrial DNA replication (GO:0006264) | 2.90165357 |
| 116 | regulation of synaptic plasticity (GO:0048167) | 2.89977843 |
| 117 | mating behavior (GO:0007617) | 2.88678505 |
| 118 | oxaloacetate metabolic process (GO:0006107) | 2.87275280 |
| 119 | macrophage activation involved in immune response (GO:0002281) | 2.87126665 |
| 120 | regulation of B cell apoptotic process (GO:0002902) | 2.86879188 |
| 121 | response to pheromone (GO:0019236) | 2.86796009 |
| 122 | regulation of dendritic spine development (GO:0060998) | 2.86137774 |
| 123 | mannosylation (GO:0097502) | 2.85095462 |
| 124 | eosinophil chemotaxis (GO:0048245) | 2.84626229 |
| 125 | nucleotide salvage (GO:0043173) | 2.83746296 |
| 126 | negative regulation of microtubule polymerization (GO:0031115) | 2.83165315 |
| 127 | cellular response to thyroid hormone stimulus (GO:0097067) | 2.82924631 |
| 128 | proline biosynthetic process (GO:0006561) | 2.82906481 |
| 129 | glucose catabolic process (GO:0006007) | 2.81980193 |
| 130 | cell communication by electrical coupling (GO:0010644) | 2.81826388 |
| 131 | negative regulation of endoplasmic reticulum calcium ion concentration (GO:0032471) | 2.81695625 |
| 132 | positive regulation of potassium ion transmembrane transport (GO:1901381) | 2.81509631 |
| 133 | G-protein coupled acetylcholine receptor signaling pathway (GO:0007213) | 2.81187178 |
| 134 | detection of calcium ion (GO:0005513) | 2.80962424 |
| 135 | positive regulation of synaptic transmission, glutamatergic (GO:0051968) | 2.79932910 |
| 136 | synapse assembly (GO:0007416) | 2.79724107 |
| 137 | regulation of ryanodine-sensitive calcium-release channel activity (GO:0060314) | 2.78685196 |
| 138 | purinergic nucleotide receptor signaling pathway (GO:0035590) | 2.78309208 |
| 139 | synapse organization (GO:0050808) | 2.77583375 |
| 140 | regulation of respiratory gaseous exchange by neurological system process (GO:0002087) | 2.76341068 |
| 141 | long-term synaptic potentiation (GO:0060291) | 2.75416113 |
| 142 | regulation of mitochondrial membrane potential (GO:0051881) | 2.74683492 |
| 143 | purine ribonucleotide transport (GO:0015868) | 2.73645460 |
| 144 | positive regulation of interleukin-8 biosynthetic process (GO:0045416) | 2.72844873 |
| 145 | prostanoid biosynthetic process (GO:0046457) | 2.72635182 |
| 146 | prostaglandin biosynthetic process (GO:0001516) | 2.72635182 |
| 147 | tetrapyrrole biosynthetic process (GO:0033014) | 2.72617746 |
| 148 | membrane depolarization (GO:0051899) | 2.72579832 |
| 149 | neuronal ion channel clustering (GO:0045161) | 2.72296942 |
| 150 | regulation of neurotransmitter secretion (GO:0046928) | 2.72146026 |
| 151 | proteasome assembly (GO:0043248) | 2.72059300 |
| 152 | positive regulation of myeloid leukocyte cytokine production involved in immune response (GO:0061081 | 2.71790814 |
| 153 | positive regulation of synaptic transmission, GABAergic (GO:0032230) | 2.71285391 |
| 154 | regulation of synaptic transmission, glutamatergic (GO:0051966) | 2.71041661 |
| 155 | neuromuscular process (GO:0050905) | 2.70758153 |
| 156 | central nervous system projection neuron axonogenesis (GO:0021952) | 2.70588789 |
| 157 | presynaptic membrane assembly (GO:0097105) | 2.69892542 |
| 158 | receptor guanylyl cyclase signaling pathway (GO:0007168) | 2.69144176 |
| 159 | cerebellar Purkinje cell differentiation (GO:0021702) | 2.69012782 |
| 160 | calcium-mediated signaling using intracellular calcium source (GO:0035584) | 2.68576017 |
| 161 | regulation of glutamate secretion (GO:0014048) | 2.68382247 |
| 162 | response to auditory stimulus (GO:0010996) | 2.68248877 |
| 163 | regulation of protein kinase A signaling (GO:0010738) | 2.68016558 |
| 164 | adult walking behavior (GO:0007628) | 2.67524553 |
| 165 | synaptic vesicle transport (GO:0048489) | 2.67400226 |
| 166 | establishment of synaptic vesicle localization (GO:0097480) | 2.67400226 |
| 167 | pyrimidine nucleoside salvage (GO:0043097) | 2.67171604 |
| 168 | pyrimidine-containing compound salvage (GO:0008655) | 2.67171604 |
| 169 | regulation of T cell chemotaxis (GO:0010819) | 2.67014955 |
| 170 | positive regulation of T cell chemotaxis (GO:0010820) | 2.67014955 |
| 171 | clathrin coat assembly (GO:0048268) | 2.66953487 |
| 172 | aminoglycoside antibiotic metabolic process (GO:0030647) | 2.66443973 |
| 173 | regulation of vesicle fusion (GO:0031338) | 2.66293867 |
| 174 | positive regulation of T cell apoptotic process (GO:0070234) | 2.65856852 |
| 175 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 2.65666494 |
| 176 | B cell mediated immunity (GO:0019724) | 2.65058404 |
| 177 | regulation of monocyte differentiation (GO:0045655) | 2.62873500 |
| 178 | regulation of T cell migration (GO:2000404) | 2.60224518 |
| 179 | tricarboxylic acid metabolic process (GO:0072350) | 2.59698727 |
| 180 | negative regulation of leukocyte apoptotic process (GO:2000107) | 2.59667127 |
| 181 | nucleoside salvage (GO:0043174) | 2.57670357 |
| 182 | positive regulation of gamma-delta T cell activation (GO:0046645) | 2.56752524 |
| 183 | pyrimidine deoxyribonucleotide metabolic process (GO:0009219) | 2.56526729 |
| 184 | pinocytosis (GO:0006907) | 2.55599628 |
| 185 | mitochondrial calcium ion transport (GO:0006851) | 2.55392638 |
| 186 | mitochondrial genome maintenance (GO:0000002) | 2.54137652 |
| 187 | response to thyroid hormone (GO:0097066) | 2.53843523 |
| 188 | extracellular fibril organization (GO:0043206) | 2.53691160 |
| 189 | eosinophil migration (GO:0072677) | 2.53041926 |
| 190 | regulation of prostaglandin secretion (GO:0032306) | 2.52168129 |
| 191 | pyrimidine nucleotide catabolic process (GO:0006244) | 2.52045305 |
| 192 | positive thymic T cell selection (GO:0045059) | 2.52041587 |
| 193 | GTP biosynthetic process (GO:0006183) | 2.51803599 |
| 194 | hemoglobin metabolic process (GO:0020027) | 2.51283265 |
| 195 | epithelial cell differentiation involved in prostate gland development (GO:0060742) | 2.49641458 |
| 196 | glycoside metabolic process (GO:0016137) | 2.49087044 |
| 197 | adenine nucleotide transport (GO:0051503) | 2.49073909 |
| 198 | mitotic nuclear envelope reassembly (GO:0007084) | 2.47748049 |
| 199 | nuclear envelope reassembly (GO:0031468) | 2.47748049 |
| 200 | purinergic receptor signaling pathway (GO:0035587) | 2.47406229 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | EZH2_22144423_ChIP-Seq_EOC_Human | 5.75020462 |
| 2 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 3.93685713 |
| 3 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 3.33072114 |
| 4 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 3.21360313 |
| 5 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 3.18609190 |
| 6 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 3.06240812 |
| 7 | GBX2_23144817_ChIP-Seq_PC3_Human | 2.97503614 |
| 8 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 2.93077553 |
| 9 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 2.79365340 |
| 10 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 2.72871340 |
| 11 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 2.69553479 |
| 12 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 2.69553479 |
| 13 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 2.67316561 |
| 14 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 2.63892612 |
| 15 | * SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 2.60966141 |
| 16 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 2.60042850 |
| 17 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 2.59747652 |
| 18 | MYBL1_21750041_ChIP-ChIP_SPERMATOCYTES_Mouse | 2.59475005 |
| 19 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 2.59057909 |
| 20 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 2.57862715 |
| 21 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 2.57117694 |
| 22 | REST_21632747_ChIP-Seq_MESCs_Mouse | 2.55952633 |
| 23 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 2.55765344 |
| 24 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 2.50176673 |
| 25 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 2.38376226 |
| 26 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 2.33672706 |
| 27 | DROSHA_22980978_ChIP-Seq_HELA_Human | 2.31779093 |
| 28 | ZNF263_19887448_ChIP-Seq_K562_Human | 2.27331962 |
| 29 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 2.23840515 |
| 30 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 2.22709013 |
| 31 | * REST_18959480_ChIP-ChIP_MESCs_Mouse | 2.20589288 |
| 32 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 2.17930294 |
| 33 | AR_21572438_ChIP-Seq_LNCaP_Human | 2.16337508 |
| 34 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 2.15912428 |
| 35 | VDR_21846776_ChIP-Seq_THP-1_Human | 2.12903795 |
| 36 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 2.12169184 |
| 37 | TAF15_26573619_Chip-Seq_HEK293_Human | 2.07852517 |
| 38 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 2.00820417 |
| 39 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.96236092 |
| 40 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.95493756 |
| 41 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 1.92415192 |
| 42 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 1.91852984 |
| 43 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.90051376 |
| 44 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.86603722 |
| 45 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 1.84976176 |
| 46 | * MYC_18358816_ChIP-ChIP_MESCs_Mouse | 1.84769658 |
| 47 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.80603952 |
| 48 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.80480401 |
| 49 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.79473873 |
| 50 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.77047240 |
| 51 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 1.76192675 |
| 52 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.76083340 |
| 53 | MYC_22102868_ChIP-Seq_BL_Human | 1.73444426 |
| 54 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.68723291 |
| 55 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.68535508 |
| 56 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 1.66945045 |
| 57 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 1.65826703 |
| 58 | * MYC_18555785_ChIP-Seq_MESCs_Mouse | 1.64098158 |
| 59 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 1.63597525 |
| 60 | CIITA_25753668_ChIP-Seq_RAJI_Human | 1.63125936 |
| 61 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.62162405 |
| 62 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.58680453 |
| 63 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.58660835 |
| 64 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.54220014 |
| 65 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.54174943 |
| 66 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 1.50571962 |
| 67 | CEBPB_24764292_ChIP-Seq_MC3T3_Mouse | 1.49847290 |
| 68 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 1.48715839 |
| 69 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.47898954 |
| 70 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 1.47543837 |
| 71 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.46943574 |
| 72 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 1.45464303 |
| 73 | YY1_21170310_ChIP-Seq_MESCs_Mouse | 1.44961337 |
| 74 | * ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.44898850 |
| 75 | * RING1B_27294783_Chip-Seq_ESCs_Mouse | 1.43467841 |
| 76 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.43319418 |
| 77 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.42864807 |
| 78 | BCL6_27268052_Chip-Seq_Bcells_Human | 1.42576256 |
| 79 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 1.41605427 |
| 80 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 1.40258926 |
| 81 | DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 1.39099088 |
| 82 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.38966246 |
| 83 | * SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.38782698 |
| 84 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 1.38778404 |
| 85 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.38051165 |
| 86 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.37583883 |
| 87 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.37232446 |
| 88 | NELFA_20434984_ChIP-Seq_ESCs_Mouse | 1.36737563 |
| 89 | ETS1_20019798_ChIP-Seq_JURKAT_Human | 1.36226997 |
| 90 | P68_20966046_ChIP-Seq_HELA_Human | 1.35224234 |
| 91 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.34764159 |
| 92 | BCOR_27268052_Chip-Seq_Bcells_Human | 1.34738949 |
| 93 | DCP1A_22483619_ChIP-Seq_HELA_Human | 1.34696824 |
| 94 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.34387263 |
| 95 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 1.33049430 |
| 96 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.32885741 |
| 97 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 1.31310086 |
| 98 | CCND1_20090754_ChIP-ChIP_RETINA_Mouse | 1.30946029 |
| 99 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 1.30801482 |
| 100 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 1.29839221 |
| 101 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 1.28816841 |
| 102 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.28494343 |
| 103 | XRN2_22483619_ChIP-Seq_HELA_Human | 1.28382228 |
| 104 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 1.27762463 |
| 105 | * CTCF_21964334_Chip-Seq_Bcells_Human | 1.27306525 |
| 106 | * SOX2_21211035_ChIP-Seq_LN229_Gbm | 1.27204230 |
| 107 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.27199933 |
| 108 | * CTCF_18555785_ChIP-Seq_MESCs_Mouse | 1.27145733 |
| 109 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 1.26718605 |
| 110 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.26717332 |
| 111 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.26597245 |
| 112 | GABP_19822575_ChIP-Seq_HepG2_Human | 1.26591634 |
| 113 | * E2F1_18555785_ChIP-Seq_MESCs_Mouse | 1.25067831 |
| 114 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.24810919 |
| 115 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.24742534 |
| 116 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 1.24705512 |
| 117 | P300_19829295_ChIP-Seq_ESCs_Human | 1.24698276 |
| 118 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.24611448 |
| 119 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 1.24344016 |
| 120 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.24154240 |
| 121 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.23904242 |
| 122 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.22784017 |
| 123 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.21883802 |
| 124 | THAP11_20581084_ChIP-Seq_MESCs_Mouse | 1.21754537 |
| 125 | RCOR3_21632747_ChIP-Seq_MESCs_Mouse | 1.21487336 |
| 126 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.20505936 |
| 127 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 1.20348878 |
| 128 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.20160337 |
| 129 | * TOP2B_26459242_ChIP-Seq_MCF-7_Human | 1.19741298 |
| 130 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 1.17770568 |
| 131 | P53_22127205_ChIP-Seq_FIBROBLAST_Human | 1.16802727 |
| 132 | UTX_26944678_Chip-Seq_JUKART_Human | 1.16484134 |
| 133 | AR_25329375_ChIP-Seq_VCAP_Human | 1.15638034 |
| 134 | MAF_26560356_Chip-Seq_TH1_Human | 1.14852945 |
| 135 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 1.14753679 |
| 136 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.14665780 |
| 137 | * ZFX_18555785_ChIP-Seq_MESCs_Mouse | 1.13430986 |
| 138 | TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 1.12809869 |
| 139 | MAF_26560356_Chip-Seq_TH2_Human | 1.12145602 |
| 140 | STAT3_23295773_ChIP-Seq_U87_Human | 1.12072339 |
| 141 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.11862762 |
| 142 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.11398828 |
| 143 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.11383133 |
| 144 | * CTCF_26484167_Chip-Seq_Bcells_Mouse | 1.11330144 |
| 145 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 1.10854658 |
| 146 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.10606120 |
| 147 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.10549115 |
| 148 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 1.10259058 |
| 149 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.09991751 |
| 150 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.09789301 |
| 151 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.09487427 |
| 152 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.09363911 |
| 153 | RNF2_27304074_Chip-Seq_NSC_Mouse | 1.08189943 |
| 154 | RING1B_27294783_Chip-Seq_NPCs_Mouse | 1.07954807 |
| 155 | BCL3_23251550_ChIP-Seq_MUSCLE_Mouse | 1.07382194 |
| 156 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 1.06783506 |
| 157 | WT1_25993318_ChIP-Seq_PODOCYTE_Human | 1.05606546 |
| 158 | AR_19668381_ChIP-Seq_PC3_Human | 1.05431051 |
| 159 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 1.05416006 |
| 160 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 1.04906075 |
| 161 | CTCF_27219007_Chip-Seq_Bcells_Human | 1.04608035 |
| 162 | * MYC_19030024_ChIP-ChIP_MESCs_Mouse | 1.04577246 |
| 163 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.04375414 |
| 164 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.03886629 |
| 165 | P300_27268052_Chip-Seq_Bcells_Human | 1.03820207 |
| 166 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 1.03808615 |
| 167 | STAT1_20625510_ChIP-Seq_HELA_Human | 1.03665293 |
| 168 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.03152186 |
| 169 | CREB1_15753290_ChIP-ChIP_HEK293T_Human | 1.02742017 |
| 170 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 1.02212804 |
| 171 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 1.02177251 |
| 172 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.02095210 |
| 173 | FUS_26573619_Chip-Seq_HEK293_Human | 1.01283545 |
| 174 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.99609139 |
| 175 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 0.99564723 |
| 176 | EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 0.97779188 |
| 177 | KDM2B_26808549_Chip-Seq_K562_Human | 0.97310256 |
| 178 | MEIS1_26923725_Chip-Seq_HEMOGENIC-ENDOTHELIUM_Mouse | 0.96718371 |
| 179 | BCAT_22108803_ChIP-Seq_LS180_Human | 0.95926645 |
| 180 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 0.94135171 |
| 181 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 0.93144297 |
| 182 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 0.93027067 |
| 183 | * TET1_21490601_ChIP-Seq_MESCs_Mouse | 0.92855333 |
| 184 | OLIG2_26023283_ChIP-Seq_AINV15_Mouse | 0.91582168 |
| 185 | YAP1_20516196_ChIP-Seq_MESCs_Mouse | 0.91112815 |
| 186 | TCF4_23295773_ChIP-Seq_U87_Human | 0.91072038 |
| 187 | TCF3_18467660_ChIP-ChIP_MESCs_Mouse | 0.90988769 |
| 188 | PRDM14_20953172_ChIP-Seq_ESCs_Human | 0.89759022 |
| 189 | AHR_22903824_ChIP-Seq_MCF-7_Human | 0.89439317 |
| 190 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 0.87716121 |
| 191 | RUNX2_22187159_ChIP-Seq_PCA_Human | 0.87695475 |
| 192 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 0.87205860 |
| 193 | * JUN_21703547_ChIP-Seq_K562_Human | 0.84107857 |
| 194 | SMAD4_21741376_ChIP-Seq_HESCs_Human | 0.81882539 |
| 195 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.81316041 |
| 196 | SMAD3_21741376_ChIP-Seq_ESCs_Human | 0.80246186 |
| 197 | MYCN_27167114_Chip-Seq_NEUROBLASTOMA_Human | 0.80196797 |
| 198 | TAL1_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.79971238 |
| 199 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 0.79819306 |
| 200 | TEAD4_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.78684165 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0004859_abnormal_synaptic_plasticity | 5.11027556 |
| 2 | MP0003880_abnormal_central_pattern | 4.29265471 |
| 3 | MP0003635_abnormal_synaptic_transmissio | 3.75182885 |
| 4 | MP0004270_analgesia | 3.72529524 |
| 5 | MP0005451_abnormal_body_composition | 3.48310832 |
| 6 | MP0009840_abnormal_foam_cell | 3.38554255 |
| 7 | MP0005058_abnormal_lysosome_morphology | 3.19510695 |
| 8 | MP0009745_abnormal_behavioral_response | 3.14031742 |
| 9 | MP0003191_abnormal_cellular_cholesterol | 3.10100237 |
| 10 | MP0002064_seizures | 3.04059852 |
| 11 | MP0003656_abnormal_erythrocyte_physiolo | 3.00760681 |
| 12 | MP0002063_abnormal_learning/memory/cond | 2.98840464 |
| 13 | MP0001545_abnormal_hematopoietic_system | 2.97676593 |
| 14 | MP0005397_hematopoietic_system_phenotyp | 2.97676593 |
| 15 | MP0003806_abnormal_nucleotide_metabolis | 2.62881524 |
| 16 | MP0002572_abnormal_emotion/affect_behav | 2.57361725 |
| 17 | MP0002272_abnormal_nervous_system | 2.56663392 |
| 18 | MP0001486_abnormal_startle_reflex | 2.54929908 |
| 19 | MP0001968_abnormal_touch/_nociception | 2.52996261 |
| 20 | MP0009046_muscle_twitch | 2.47009560 |
| 21 | MP0001529_abnormal_vocalization | 2.43643516 |
| 22 | MP0005423_abnormal_somatic_nervous | 2.43371469 |
| 23 | MP0006276_abnormal_autonomic_nervous | 2.41821519 |
| 24 | MP0003329_amyloid_beta_deposits | 2.35099167 |
| 25 | MP0001440_abnormal_grooming_behavior | 2.28590933 |
| 26 | MP0002734_abnormal_mechanical_nocicepti | 2.24218201 |
| 27 | MP0002138_abnormal_hepatobiliary_system | 2.22415639 |
| 28 | MP0005464_abnormal_platelet_physiology | 2.15372849 |
| 29 | MP0002837_dystrophic_cardiac_calcinosis | 2.10953068 |
| 30 | MP0003186_abnormal_redox_activity | 2.10215264 |
| 31 | MP0000751_myopathy | 2.05306561 |
| 32 | MP0002132_abnormal_respiratory_system | 2.02916338 |
| 33 | MP0002877_abnormal_melanocyte_morpholog | 1.97353563 |
| 34 | MP0002733_abnormal_thermal_nociception | 1.92603216 |
| 35 | MP0002735_abnormal_chemical_nociception | 1.89749638 |
| 36 | MP0001835_abnormal_antigen_presentation | 1.89366203 |
| 37 | MP0000778_abnormal_nervous_system | 1.89167358 |
| 38 | MP0002067_abnormal_sensory_capabilities | 1.88522190 |
| 39 | MP0003183_abnormal_peptide_metabolism | 1.88225194 |
| 40 | MP0002184_abnormal_innervation | 1.87046160 |
| 41 | MP0002736_abnormal_nociception_after | 1.86329324 |
| 42 | MP0002909_abnormal_adrenal_gland | 1.85280035 |
| 43 | MP0005671_abnormal_response_to | 1.84951069 |
| 44 | MP0002148_abnormal_hypersensitivity_rea | 1.82304730 |
| 45 | MP0001970_abnormal_pain_threshold | 1.79449753 |
| 46 | MP0004924_abnormal_behavior | 1.78520638 |
| 47 | MP0005386_behavior/neurological_phenoty | 1.78520638 |
| 48 | MP0005165_increased_susceptibility_to | 1.77075216 |
| 49 | MP0009333_abnormal_splenocyte_physiolog | 1.77049269 |
| 50 | MP0003122_maternal_imprinting | 1.76115809 |
| 51 | MP0008260_abnormal_autophagy | 1.74962738 |
| 52 | MP0001853_heart_inflammation | 1.74414207 |
| 53 | MP0001542_abnormal_bone_strength | 1.73635297 |
| 54 | MP0002822_catalepsy | 1.72869555 |
| 55 | MP0009278_abnormal_bone_marrow | 1.71830803 |
| 56 | MP0003436_decreased_susceptibility_to | 1.70529508 |
| 57 | MP0004147_increased_porphyrin_level | 1.70301286 |
| 58 | MP0005645_abnormal_hypothalamus_physiol | 1.68723052 |
| 59 | MP0003879_abnormal_hair_cell | 1.66725949 |
| 60 | MP0000015_abnormal_ear_pigmentation | 1.65089752 |
| 61 | MP0001501_abnormal_sleep_pattern | 1.62088337 |
| 62 | MP0001984_abnormal_olfaction | 1.61079221 |
| 63 | MP0001485_abnormal_pinna_reflex | 1.57971647 |
| 64 | MP0004145_abnormal_muscle_electrophysio | 1.56707978 |
| 65 | MP0002557_abnormal_social/conspecific_i | 1.55987180 |
| 66 | MP0005000_abnormal_immune_tolerance | 1.55957132 |
| 67 | MP0001502_abnormal_circadian_rhythm | 1.55597939 |
| 68 | MP0002396_abnormal_hematopoietic_system | 1.53423918 |
| 69 | MP0005025_abnormal_response_to | 1.53235675 |
| 70 | MP0008438_abnormal_cutaneous_collagen | 1.53044654 |
| 71 | MP0001905_abnormal_dopamine_level | 1.52336030 |
| 72 | MP0008569_lethality_at_weaning | 1.51475446 |
| 73 | MP0002452_abnormal_antigen_presenting | 1.51259975 |
| 74 | MP0000920_abnormal_myelination | 1.49677001 |
| 75 | MP0002882_abnormal_neuron_morphology | 1.48053575 |
| 76 | MP0001800_abnormal_humoral_immune | 1.46878738 |
| 77 | MP0000689_abnormal_spleen_morphology | 1.46670631 |
| 78 | MP0000955_abnormal_spinal_cord | 1.46528245 |
| 79 | MP0004811_abnormal_neuron_physiology | 1.46258546 |
| 80 | MP0002723_abnormal_immune_serum | 1.45980080 |
| 81 | MP0002066_abnormal_motor_capabilities/c | 1.45945693 |
| 82 | MP0004142_abnormal_muscle_tone | 1.45698163 |
| 83 | MP0004885_abnormal_endolymph | 1.44094691 |
| 84 | MP0004858_abnormal_nervous_system | 1.42952215 |
| 85 | MP0002419_abnormal_innate_immunity | 1.41981787 |
| 86 | MP0004742_abnormal_vestibular_system | 1.41684778 |
| 87 | MP0009780_abnormal_chondrocyte_physiolo | 1.39342949 |
| 88 | MP0005257_abnormal_intraocular_pressure | 1.38009114 |
| 89 | MP0004510_myositis | 1.35210183 |
| 90 | MP0004215_abnormal_myocardial_fiber | 1.34611645 |
| 91 | MP0003633_abnormal_nervous_system | 1.33518599 |
| 92 | MP0008469_abnormal_protein_level | 1.33389610 |
| 93 | MP0000747_muscle_weakness | 1.32843173 |
| 94 | MP0005551_abnormal_eye_electrophysiolog | 1.32512453 |
| 95 | MP0002420_abnormal_adaptive_immunity | 1.32465832 |
| 96 | MP0001819_abnormal_immune_cell | 1.32166604 |
| 97 | MP0003137_abnormal_impulse_conducting | 1.31373620 |
| 98 | MP0001881_abnormal_mammary_gland | 1.30402436 |
| 99 | MP0002398_abnormal_bone_marrow | 1.27749546 |
| 100 | MP0002229_neurodegeneration | 1.25933852 |
| 101 | MP0000465_gastrointestinal_hemorrhage | 1.25555492 |
| 102 | MP0006036_abnormal_mitochondrial_physio | 1.25331082 |
| 103 | MP0005075_abnormal_melanosome_morpholog | 1.23641832 |
| 104 | MP0000604_amyloidosis | 1.22676948 |
| 105 | MP0009785_altered_susceptibility_to | 1.22202367 |
| 106 | MP0001727_abnormal_embryo_implantation | 1.22037584 |
| 107 | MP0000343_altered_response_to | 1.21345743 |
| 108 | MP0002429_abnormal_blood_cell | 1.21202603 |
| 109 | MP0001790_abnormal_immune_system | 1.20206147 |
| 110 | MP0005387_immune_system_phenotype | 1.20206147 |
| 111 | MP0003634_abnormal_glial_cell | 1.18013774 |
| 112 | MP0000716_abnormal_immune_system | 1.15084333 |
| 113 | MP0003303_peritoneal_inflammation | 1.14012605 |
| 114 | MP0001533_abnormal_skeleton_physiology | 1.11970933 |
| 115 | MP0003631_nervous_system_phenotype | 1.10788790 |
| 116 | MP0002638_abnormal_pupillary_reflex | 1.10426603 |
| 117 | MP0005646_abnormal_pituitary_gland | 1.10221616 |
| 118 | MP0004085_abnormal_heartbeat | 1.09816220 |
| 119 | MP0002722_abnormal_immune_system | 1.09390705 |
| 120 | MP0002405_respiratory_system_inflammati | 1.09213459 |
| 121 | MP0005636_abnormal_mineral_homeostasis | 1.09042508 |
| 122 | MP0002152_abnormal_brain_morphology | 1.07905191 |
| 123 | MP0003763_abnormal_thymus_physiology | 1.07648799 |
| 124 | MP0003690_abnormal_glial_cell | 1.07268560 |
| 125 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.06150475 |
| 126 | MP0009764_decreased_sensitivity_to | 1.05011883 |
| 127 | MP0001243_abnormal_dermal_layer | 1.04503918 |
| 128 | MP0006082_CNS_inflammation | 1.00722896 |
| 129 | MP0002090_abnormal_vision | 1.00609755 |
| 130 | MP0002019_abnormal_tumor_incidence | 1.00296452 |
| 131 | MP0005535_abnormal_body_temperature | 0.99916531 |
| 132 | MP0000685_abnormal_immune_system | 0.99717405 |
| 133 | MP0000681_abnormal_thyroid_gland | 0.98452784 |
| 134 | MP0008874_decreased_physiological_sensi | 0.97673192 |
| 135 | MP0004036_abnormal_muscle_relaxation | 0.97448462 |
| 136 | MP0004808_abnormal_hematopoietic_stem | 0.97196174 |
| 137 | MP0009931_abnormal_skin_appearance | 0.96945656 |
| 138 | MP0002060_abnormal_skin_morphology | 0.96922894 |
| 139 | MP0003300_gastrointestinal_ulcer | 0.96658032 |
| 140 | MP0001845_abnormal_inflammatory_respons | 0.96227808 |
| 141 | MP0000750_abnormal_muscle_regeneration | 0.95919074 |
| 142 | MP0002069_abnormal_eating/drinking_beha | 0.95500407 |
| 143 | MP0004043_abnormal_pH_regulation | 0.92367693 |
| 144 | MP0002752_abnormal_somatic_nervous | 0.92069986 |
| 145 | MP0003718_maternal_effect | 0.90846559 |
| 146 | MP0005319_abnormal_enzyme/_coenzyme | 0.90562551 |
| 147 | MP0001963_abnormal_hearing_physiology | 0.89524114 |
| 148 | MP0001849_ear_inflammation | 0.86854888 |
| 149 | MP0000013_abnormal_adipose_tissue | 0.86606405 |
| 150 | MP0006072_abnormal_retinal_apoptosis | 0.86183563 |
| 151 | MP0005501_abnormal_skin_physiology | 0.82642266 |
| 152 | MP0001873_stomach_inflammation | 0.82601413 |
| 153 | MP0002139_abnormal_hepatobiliary_system | 0.81938259 |
| 154 | MP0008872_abnormal_physiological_respon | 0.81889624 |
| 155 | MP0000609_abnormal_liver_physiology | 0.81673212 |
| 156 | MP0005166_decreased_susceptibility_to | 0.81102088 |
| 157 | MP0004130_abnormal_muscle_cell | 0.80573806 |
| 158 | MP0010155_abnormal_intestine_physiology | 0.80269429 |
| 159 | MP0005390_skeleton_phenotype | 0.80078525 |
| 160 | MP0003787_abnormal_imprinting | 0.79750791 |
| 161 | MP0003632_abnormal_nervous_system | 0.79302818 |
| 162 | MP0004947_skin_inflammation | 0.78609124 |
| 163 | MP0004185_abnormal_adipocyte_glucose | 0.78261326 |
| 164 | MP0001661_extended_life_span | 0.75800383 |
| 165 | MP0003786_premature_aging | 0.75763550 |
| 166 | MP0000631_abnormal_neuroendocrine_gland | 0.74467566 |
| 167 | MP0003075_altered_response_to | 0.72676574 |
| 168 | MP0000749_muscle_degeneration | 0.72615366 |
| 169 | MP0008961_abnormal_basal_metabolism | 0.72225012 |
| 170 | MP0005620_abnormal_muscle_contractility | 0.72212728 |
| 171 | MP0005330_cardiomyopathy | 0.72021502 |
| 172 | MP0001958_emphysema | 0.71579687 |
| 173 | MP0003646_muscle_fatigue | 0.71315656 |
| 174 | MP0003172_abnormal_lysosome_physiology | 0.71147482 |
| 175 | MP0003279_aneurysm | 0.70962269 |
| 176 | MP0000627_abnormal_mammary_gland | 0.70556108 |
| 177 | MP0003566_abnormal_cell_adhesion | 0.70347685 |
| 178 | MP0009643_abnormal_urine_homeostasis | 0.69753117 |
| 179 | MP0000371_diluted_coat_color | 0.69739719 |
| 180 | MP0005253_abnormal_eye_physiology | 0.68256481 |
| 181 | MP0004233_abnormal_muscle_weight | 0.67264387 |
| 182 | MP0005499_abnormal_olfactory_system | 0.66814866 |
| 183 | MP0005394_taste/olfaction_phenotype | 0.66814866 |
| 184 | MP0004484_altered_response_of | 0.63123731 |
| 185 | MP0001943_abnormal_respiration | 0.61511072 |
| 186 | MP0005623_abnormal_meninges_morphology | 0.60971304 |
| 187 | MP0005187_abnormal_penis_morphology | 0.56296693 |
| 188 | MP0005409_darkened_coat_color | 0.54948315 |
| 189 | MP0002972_abnormal_cardiac_muscle | 0.54504633 |
| 190 | MP0000759_abnormal_skeletal_muscle | 0.52966949 |
| 191 | MP0001177_atelectasis | 0.52905752 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | * Focal motor seizures (HP:0011153) | 6.26705391 |
| 2 | Myokymia (HP:0002411) | 5.73375821 |
| 3 | * Focal seizures (HP:0007359) | 5.18420123 |
| 4 | * Visual hallucinations (HP:0002367) | 5.07088513 |
| 5 | Abnormality of liposaccharide metabolism (HP:0010968) | 4.25242217 |
| 6 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 4.25242217 |
| 7 | Abnormality of glycolipid metabolism (HP:0010969) | 4.25242217 |
| 8 | * Absence seizures (HP:0002121) | 4.19608336 |
| 9 | Microvesicular hepatic steatosis (HP:0001414) | 4.16112058 |
| 10 | Agammaglobulinemia (HP:0004432) | 3.96108254 |
| 11 | * Dialeptic seizures (HP:0011146) | 3.95981521 |
| 12 | Epileptic encephalopathy (HP:0200134) | 3.72016014 |
| 13 | Supranuclear gaze palsy (HP:0000605) | 3.68040716 |
| 14 | Nonimmune hydrops fetalis (HP:0001790) | 3.60294061 |
| 15 | Increased serum ferritin (HP:0003281) | 3.59465838 |
| 16 | Abnormality of the heme biosynthetic pathway (HP:0010472) | 3.55848666 |
| 17 | Decreased electroretinogram (ERG) amplitude (HP:0000654) | 3.54529780 |
| 18 | Atonic seizures (HP:0010819) | 3.46716913 |
| 19 | Cellulitis (HP:0100658) | 3.37362363 |
| 20 | Pheochromocytoma (HP:0002666) | 3.35731049 |
| 21 | Type I transferrin isoform profile (HP:0003642) | 3.34996330 |
| 22 | Neurofibrillary tangles (HP:0002185) | 3.34719183 |
| 23 | Ankle clonus (HP:0011448) | 3.24856152 |
| 24 | Cerebral inclusion bodies (HP:0100314) | 3.17747892 |
| 25 | Febrile seizures (HP:0002373) | 3.15335586 |
| 26 | Rhabdomyolysis (HP:0003201) | 3.15200068 |
| 27 | Progressive cerebellar ataxia (HP:0002073) | 3.11229985 |
| 28 | * Generalized tonic-clonic seizures (HP:0002069) | 3.10810636 |
| 29 | Termporal pattern (HP:0011008) | 3.06953734 |
| 30 | Insidious onset (HP:0003587) | 3.06953734 |
| 31 | Abnormality of iron homeostasis (HP:0011031) | 3.06852357 |
| 32 | Distal lower limb muscle weakness (HP:0009053) | 3.04694722 |
| 33 | Dysostosis multiplex (HP:0000943) | 3.04566504 |
| 34 | J-shaped sella turcica (HP:0002680) | 3.00738070 |
| 35 | Increased intramyocellular lipid droplets (HP:0012240) | 3.00439982 |
| 36 | Increased cerebral lipofuscin (HP:0011813) | 3.00335885 |
| 37 | Action tremor (HP:0002345) | 2.99740941 |
| 38 | Reduced antithrombin III activity (HP:0001976) | 2.98208794 |
| 39 | Spastic gait (HP:0002064) | 2.94706508 |
| 40 | Depression (HP:0000716) | 2.94698941 |
| 41 | Increased muscle lipid content (HP:0009058) | 2.93974020 |
| 42 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 2.92618971 |
| 43 | Abnormality of polysaccharide metabolism (HP:0011012) | 2.92618971 |
| 44 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 2.92618971 |
| 45 | Vacuolated lymphocytes (HP:0001922) | 2.88120156 |
| 46 | Dysmetria (HP:0001310) | 2.86461873 |
| 47 | Prolonged neonatal jaundice (HP:0006579) | 2.85928710 |
| 48 | Anxiety (HP:0000739) | 2.85262309 |
| 49 | Neuroendocrine neoplasm (HP:0100634) | 2.85161667 |
| 50 | Truncal ataxia (HP:0002078) | 2.84762878 |
| 51 | Hyperventilation (HP:0002883) | 2.81501912 |
| 52 | Abnormal protein glycosylation (HP:0012346) | 2.81122130 |
| 53 | Abnormal glycosylation (HP:0012345) | 2.81122130 |
| 54 | Abnormal isoelectric focusing of serum transferrin (HP:0003160) | 2.81122130 |
| 55 | Abnormal protein N-linked glycosylation (HP:0012347) | 2.81122130 |
| 56 | Dysdiadochokinesis (HP:0002075) | 2.80351979 |
| 57 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 2.79958580 |
| 58 | Broad-based gait (HP:0002136) | 2.77970871 |
| 59 | Peripheral hypomyelination (HP:0007182) | 2.75484479 |
| 60 | Poor eye contact (HP:0000817) | 2.73329800 |
| 61 | Urinary urgency (HP:0000012) | 2.70704261 |
| 62 | Vertebral compression fractures (HP:0002953) | 2.69730465 |
| 63 | Postural instability (HP:0002172) | 2.68444965 |
| 64 | Centrally nucleated skeletal muscle fibers (HP:0003687) | 2.68172699 |
| 65 | Reticulocytosis (HP:0001923) | 2.67029006 |
| 66 | Abnormality of the corticospinal tract (HP:0002492) | 2.66036078 |
| 67 | Abnormal eating behavior (HP:0100738) | 2.63672282 |
| 68 | Urinary glycosaminoglycan excretion (HP:0003541) | 2.63555462 |
| 69 | Mucopolysacchariduria (HP:0008155) | 2.63555462 |
| 70 | Impaired vibration sensation in the lower limbs (HP:0002166) | 2.61914495 |
| 71 | Exercise-induced myalgia (HP:0003738) | 2.61011723 |
| 72 | Impaired social interactions (HP:0000735) | 2.60469642 |
| 73 | Abnormal social behavior (HP:0012433) | 2.60469642 |
| 74 | Abnormality of transition element cation homeostasis (HP:0011030) | 2.60454840 |
| 75 | Failure to thrive in infancy (HP:0001531) | 2.56455819 |
| 76 | Progressive inability to walk (HP:0002505) | 2.53675046 |
| 77 | Mutism (HP:0002300) | 2.52075259 |
| 78 | Atrophy/Degeneration involving the corticospinal tracts (HP:0007372) | 2.51645970 |
| 79 | Degeneration of the lateral corticospinal tracts (HP:0002314) | 2.51645970 |
| 80 | Decreased central vision (HP:0007663) | 2.51008862 |
| 81 | Hepatosplenomegaly (HP:0001433) | 2.46084815 |
| 82 | Distal lower limb amyotrophy (HP:0008944) | 2.44251146 |
| 83 | Gaze-evoked nystagmus (HP:0000640) | 2.40417414 |
| 84 | Intention tremor (HP:0002080) | 2.39342192 |
| 85 | Urinary bladder sphincter dysfunction (HP:0002839) | 2.38608423 |
| 86 | Generalized amyotrophy (HP:0003700) | 2.37648648 |
| 87 | Drooling (HP:0002307) | 2.35365216 |
| 88 | Excessive salivation (HP:0003781) | 2.35365216 |
| 89 | Sudden death (HP:0001699) | 2.31847739 |
| 90 | Polyphagia (HP:0002591) | 2.30999130 |
| 91 | Muscle hypertrophy of the lower extremities (HP:0008968) | 2.28958243 |
| 92 | Petechiae (HP:0000967) | 2.28160376 |
| 93 | Epileptiform EEG discharges (HP:0011182) | 2.24861416 |
| 94 | Amyotrophic lateral sclerosis (HP:0007354) | 2.24220137 |
| 95 | EEG with generalized epileptiform discharges (HP:0011198) | 2.23162284 |
| 96 | Loss of speech (HP:0002371) | 2.21166733 |
| 97 | Cerebral palsy (HP:0100021) | 2.20329279 |
| 98 | Torticollis (HP:0000473) | 2.19610334 |
| 99 | Premature rupture of membranes (HP:0001788) | 2.19407661 |
| 100 | Osteomyelitis (HP:0002754) | 2.18679623 |
| 101 | Mediastinal lymphadenopathy (HP:0100721) | 2.17857717 |
| 102 | Autoamputation (HP:0001218) | 2.17425665 |
| 103 | Scanning speech (HP:0002168) | 2.16998559 |
| 104 | Central scotoma (HP:0000603) | 2.16440412 |
| 105 | Dicarboxylic aciduria (HP:0003215) | 2.15560663 |
| 106 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 2.15560663 |
| 107 | Ragged-red muscle fibers (HP:0003200) | 2.15433814 |
| 108 | Recurrent viral infections (HP:0004429) | 2.15041509 |
| 109 | Fetal akinesia sequence (HP:0001989) | 2.14040862 |
| 110 | Hepatocellular necrosis (HP:0001404) | 2.13995583 |
| 111 | Asymmetric septal hypertrophy (HP:0001670) | 2.13282092 |
| 112 | Aplastic anemia (HP:0001915) | 2.13239830 |
| 113 | Abnormal number of erythroid precursors (HP:0012131) | 2.13185067 |
| 114 | Lower limb muscle weakness (HP:0007340) | 2.13065143 |
| 115 | Hypsarrhythmia (HP:0002521) | 2.12101357 |
| 116 | Increased serum pyruvate (HP:0003542) | 2.12013393 |
| 117 | Abnormality of glycolysis (HP:0004366) | 2.12013393 |
| 118 | Gastrointestinal stroma tumor (HP:0100723) | 2.11031754 |
| 119 | Abnormality of macrophages (HP:0004311) | 2.10976654 |
| 120 | Polycythemia (HP:0001901) | 2.10686868 |
| 121 | Clumsiness (HP:0002312) | 2.10638221 |
| 122 | Epistaxis (HP:0000421) | 2.08861822 |
| 123 | Amyloidosis (HP:0011034) | 2.07470024 |
| 124 | Elevated erythrocyte sedimentation rate (HP:0003565) | 2.07459041 |
| 125 | Calf muscle hypertrophy (HP:0008981) | 2.07004344 |
| 126 | Amblyopia (HP:0000646) | 2.05583772 |
| 127 | Decreased activity of mitochondrial respiratory chain (HP:0008972) | 2.05555086 |
| 128 | Abnormal activity of mitochondrial respiratory chain (HP:0011922) | 2.05555086 |
| 129 | Cholelithiasis (HP:0001081) | 2.05478025 |
| 130 | Ventricular fibrillation (HP:0001663) | 2.04699948 |
| 131 | Neoplasm of the peripheral nervous system (HP:0100007) | 2.04230963 |
| 132 | Abnormal gallbladder physiology (HP:0012438) | 2.03420895 |
| 133 | Cholecystitis (HP:0001082) | 2.03420895 |
| 134 | Poor suck (HP:0002033) | 2.03352208 |
| 135 | Prolonged bleeding time (HP:0003010) | 2.02689837 |
| 136 | Nemaline bodies (HP:0003798) | 2.01057656 |
| 137 | Limb-girdle muscle atrophy (HP:0003797) | 2.01042134 |
| 138 | Achilles tendon contracture (HP:0001771) | 2.00808316 |
| 139 | Recurrent bronchitis (HP:0002837) | 1.99747354 |
| 140 | Oligomenorrhea (HP:0000876) | 1.98970936 |
| 141 | Akinesia (HP:0002304) | 1.98896591 |
| 142 | Hemiparesis (HP:0001269) | 1.97991002 |
| 143 | Cone-rod dystrophy (HP:0000548) | 1.97175353 |
| 144 | Clonus (HP:0002169) | 1.97006494 |
| 145 | Focal dystonia (HP:0004373) | 1.96471167 |
| 146 | Bradykinesia (HP:0002067) | 1.96379221 |
| 147 | Secondary amenorrhea (HP:0000869) | 1.95699838 |
| 148 | Abnormality of the lower motor neuron (HP:0002366) | 1.95603836 |
| 149 | Diplopia (HP:0000651) | 1.95093037 |
| 150 | Abnormality of binocular vision (HP:0011514) | 1.95093037 |
| 151 | Inability to walk (HP:0002540) | 1.94788935 |
| 152 | Rigidity (HP:0002063) | 1.94361897 |
| 153 | Skin rash (HP:0000988) | 1.93499798 |
| 154 | Neuronal loss in central nervous system (HP:0002529) | 1.92643323 |
| 155 | * Rapidly progressive (HP:0003678) | 1.92633096 |
| 156 | Limb dystonia (HP:0002451) | 1.92427800 |
| 157 | Hepatic necrosis (HP:0002605) | 1.92296502 |
| 158 | * Psychosis (HP:0000709) | 1.90139102 |
| 159 | Natal tooth (HP:0000695) | 1.89550667 |
| 160 | Papilledema (HP:0001085) | 1.89413714 |
| 161 | * Generalized myoclonic seizures (HP:0002123) | 1.89262658 |
| 162 | Acanthocytosis (HP:0001927) | 1.89160707 |
| 163 | Sensorimotor neuropathy (HP:0007141) | 1.88725844 |
| 164 | Genetic anticipation (HP:0003743) | 1.87273164 |
| 165 | Impaired smooth pursuit (HP:0007772) | 1.86136592 |
| 166 | Impaired vibratory sensation (HP:0002495) | 1.85865868 |
| 167 | Craniofacial dystonia (HP:0012179) | 1.85131669 |
| 168 | Postural tremor (HP:0002174) | 1.84800851 |
| 169 | Blue irides (HP:0000635) | 1.84119204 |
| 170 | Hamartoma of the eye (HP:0010568) | 1.83963736 |
| 171 | Muscle fiber cytoplasmatic inclusion bodies (HP:0100303) | 1.82810922 |
| 172 | Hypoplasia of the brainstem (HP:0002365) | 1.82741055 |
| 173 | Aplasia/Hypoplasia of the brainstem (HP:0007362) | 1.82741055 |
| 174 | Abnormality of the calf musculature (HP:0001430) | 1.82705449 |
| 175 | Myoglobinuria (HP:0002913) | 1.82522214 |
| 176 | Meningitis (HP:0001287) | 1.82421938 |
| 177 | Hypergonadotropic hypogonadism (HP:0000815) | 1.80976268 |
| 178 | Abnormality of ocular smooth pursuit (HP:0000617) | 1.80869620 |
| 179 | Muscle fiber inclusion bodies (HP:0100299) | 1.80833872 |
| 180 | Hypokinesia (HP:0002375) | 1.80348647 |
| 181 | Prolonged QT interval (HP:0001657) | 1.80268951 |
| 182 | Delusions (HP:0000746) | 1.80173555 |
| 183 | Gingival bleeding (HP:0000225) | 1.79914651 |
| 184 | Onycholysis (HP:0001806) | 1.79897952 |
| 185 | Status epilepticus (HP:0002133) | 1.79365637 |
| 186 | Syncope (HP:0001279) | 1.78413814 |
| 187 | Abnormality of the Achilles tendon (HP:0005109) | 1.77603401 |
| 188 | Joint stiffness (HP:0001387) | 1.76139983 |
| 189 | Hyperbilirubinemia (HP:0002904) | 1.76057663 |
| 190 | Testicular atrophy (HP:0000029) | 1.75590468 |
| 191 | Cardiomegaly (HP:0001640) | 1.75355172 |
| 192 | Abnormality of cells of the erythroid lineage (HP:0012130) | 1.73522506 |
| 193 | Abnormality of skeletal muscle fiber size (HP:0012084) | 1.72965844 |
| 194 | Neoplasm of head and neck (HP:0012288) | 1.71814306 |
| 195 | Esophageal neoplasm (HP:0100751) | 1.71814306 |
| 196 | Abnormal gallbladder morphology (HP:0012437) | 1.71281126 |
| 197 | Abnormal platelet function (HP:0011869) | 1.71195976 |
| 198 | Impaired platelet aggregation (HP:0003540) | 1.71195976 |
| 199 | Thoracic kyphosis (HP:0002942) | 1.71049497 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ERN1 | 4.69720499 |
| 2 | NME2 | 4.59005313 |
| 3 | PIM2 | 3.91741098 |
| 4 | MAP3K9 | 3.90507552 |
| 5 | NTRK3 | 3.68321341 |
| 6 | SCYL2 | 3.43082843 |
| 7 | MAP3K12 | 3.37696369 |
| 8 | VRK2 | 3.27630011 |
| 9 | TESK2 | 3.06618016 |
| 10 | EPHA4 | 2.97697991 |
| 11 | MARK1 | 2.96085766 |
| 12 | MAP3K4 | 2.68260306 |
| 13 | TESK1 | 2.55907530 |
| 14 | BUB1 | 2.45357591 |
| 15 | PAK6 | 2.43373397 |
| 16 | KDR | 2.42282181 |
| 17 | PNCK | 2.39722572 |
| 18 | MINK1 | 2.36487361 |
| 19 | IRAK3 | 2.35301767 |
| 20 | MAP2K4 | 2.30436495 |
| 21 | NTRK2 | 2.25509515 |
| 22 | KSR2 | 2.11797655 |
| 23 | KSR1 | 1.97688567 |
| 24 | PHKG2 | 1.88726015 |
| 25 | PHKG1 | 1.88726015 |
| 26 | BCKDK | 1.86835339 |
| 27 | STK10 | 1.76394843 |
| 28 | MAP2K7 | 1.69007237 |
| 29 | TYRO3 | 1.67727174 |
| 30 | UHMK1 | 1.67057854 |
| 31 | JAK3 | 1.61537902 |
| 32 | MAPKAPK3 | 1.59147862 |
| 33 | NTRK1 | 1.54843955 |
| 34 | STK39 | 1.54143118 |
| 35 | TAOK2 | 1.53755858 |
| 36 | CDK19 | 1.52769540 |
| 37 | TBK1 | 1.51003540 |
| 38 | CDK5 | 1.49412527 |
| 39 | MAP4K2 | 1.44352976 |
| 40 | BLK | 1.43973532 |
| 41 | DAPK2 | 1.43635643 |
| 42 | TGFBR2 | 1.41157242 |
| 43 | ARAF | 1.41073574 |
| 44 | ABL2 | 1.40373824 |
| 45 | EPHA2 | 1.37116303 |
| 46 | MAP3K2 | 1.34720998 |
| 47 | PAK3 | 1.33655044 |
| 48 | MAP3K13 | 1.33635769 |
| 49 | OXSR1 | 1.31609861 |
| 50 | MOS | 1.30523962 |
| 51 | CASK | 1.27901074 |
| 52 | FES | 1.20902712 |
| 53 | SIK2 | 1.18069262 |
| 54 | SIK3 | 1.17534308 |
| 55 | CAMKK1 | 1.17525100 |
| 56 | FGFR2 | 1.15863371 |
| 57 | CAMKK2 | 1.14605301 |
| 58 | CAMK2A | 1.14146837 |
| 59 | MATK | 1.13473496 |
| 60 | CAMK2B | 1.13397944 |
| 61 | PRKD3 | 1.10935216 |
| 62 | MAPK13 | 1.10815954 |
| 63 | MUSK | 1.10407609 |
| 64 | RIPK4 | 1.07141430 |
| 65 | PBK | 1.05423085 |
| 66 | ZAP70 | 1.03199565 |
| 67 | CDK18 | 1.02854625 |
| 68 | TNIK | 1.02080504 |
| 69 | SMG1 | 1.01860504 |
| 70 | EIF2AK1 | 0.99473736 |
| 71 | MARK2 | 0.98968965 |
| 72 | MAP3K11 | 0.98424560 |
| 73 | CDK15 | 0.97947544 |
| 74 | GRK5 | 0.97608248 |
| 75 | CCNB1 | 0.97543796 |
| 76 | CDK14 | 0.96074904 |
| 77 | MAP3K8 | 0.95105462 |
| 78 | RAF1 | 0.92287516 |
| 79 | RET | 0.91534100 |
| 80 | PLK2 | 0.89319279 |
| 81 | TRPM7 | 0.89065206 |
| 82 | MAP3K1 | 0.88346150 |
| 83 | IKBKE | 0.86082271 |
| 84 | SYK | 0.85768870 |
| 85 | MAPKAPK5 | 0.85735335 |
| 86 | CDK11A | 0.85484314 |
| 87 | CAMK2D | 0.84279252 |
| 88 | DAPK1 | 0.84153025 |
| 89 | CAMK2G | 0.84125404 |
| 90 | MAP4K1 | 0.84098367 |
| 91 | TTN | 0.83848268 |
| 92 | LMTK2 | 0.82993818 |
| 93 | CAMK1G | 0.81461100 |
| 94 | BCR | 0.81230862 |
| 95 | PRKCG | 0.81036313 |
| 96 | FER | 0.80528326 |
| 97 | NEK1 | 0.80097495 |
| 98 | MAP2K3 | 0.78876154 |
| 99 | CAMK1 | 0.78669049 |
| 100 | IKBKB | 0.78621917 |
| 101 | AURKA | 0.76536773 |
| 102 | LATS2 | 0.76018756 |
| 103 | SGK223 | 0.73516520 |
| 104 | SGK494 | 0.73516520 |
| 105 | TAOK1 | 0.73055262 |
| 106 | TXK | 0.72361967 |
| 107 | CSNK1G2 | 0.71690355 |
| 108 | SIK1 | 0.71633193 |
| 109 | WNK4 | 0.70413728 |
| 110 | FGR | 0.69061743 |
| 111 | EPHB1 | 0.68765095 |
| 112 | PAK4 | 0.68594080 |
| 113 | RIPK1 | 0.67668036 |
| 114 | LRRK2 | 0.66018866 |
| 115 | PKN1 | 0.64563228 |
| 116 | MAPKAPK2 | 0.64471477 |
| 117 | RPS6KB2 | 0.63635503 |
| 118 | MAP3K7 | 0.63592170 |
| 119 | NME1 | 0.63294826 |
| 120 | PRKCH | 0.63275183 |
| 121 | ROCK2 | 0.63145734 |
| 122 | NUAK1 | 0.62879193 |
| 123 | PAK1 | 0.62515178 |
| 124 | STK11 | 0.62491047 |
| 125 | PINK1 | 0.62094989 |
| 126 | TYK2 | 0.61891139 |
| 127 | MAPK11 | 0.61840379 |
| 128 | CLK1 | 0.60181876 |
| 129 | GRK7 | 0.60076742 |
| 130 | PRPF4B | 0.58776724 |
| 131 | PTK2B | 0.58702150 |
| 132 | STK38 | 0.58314066 |
| 133 | BTK | 0.58177373 |
| 134 | SGK1 | 0.57192457 |
| 135 | DAPK3 | 0.56335014 |
| 136 | MAP3K3 | 0.56022528 |
| 137 | TRIB3 | 0.53389416 |
| 138 | ICK | 0.53014545 |
| 139 | LIMK1 | 0.50146310 |
| 140 | ILK | 0.49828565 |
| 141 | JAK2 | 0.48848132 |
| 142 | MAP3K6 | 0.48759891 |
| 143 | IRAK2 | 0.47615371 |
| 144 | PRKCE | 0.46013653 |
| 145 | DYRK1B | 0.45869861 |
| 146 | MST4 | 0.44821589 |
| 147 | MAPK12 | 0.44664528 |
| 148 | DYRK1A | 0.43885340 |
| 149 | OBSCN | 0.43238737 |
| 150 | PRKCI | 0.43086182 |
| 151 | FYN | 0.42865017 |
| 152 | RPS6KA3 | 0.41928782 |
| 153 | CAMK4 | 0.41434500 |
| 154 | CSF1R | 0.40967270 |
| 155 | LYN | 0.39815945 |
| 156 | TNK2 | 0.39114300 |
| 157 | PAK2 | 0.39016901 |
| 158 | PRKACA | 0.38306735 |
| 159 | MAPK10 | 0.38242385 |
| 160 | MAP2K1 | 0.37617269 |
| 161 | IRAK4 | 0.36974083 |
| 162 | PIM1 | 0.36755880 |
| 163 | PDPK1 | 0.36752621 |
| 164 | CSNK1G3 | 0.36091153 |
| 165 | MAP3K5 | 0.35845507 |
| 166 | ADRBK1 | 0.35807551 |
| 167 | MYLK | 0.35726446 |
| 168 | PRKCQ | 0.32599499 |
| 169 | GRK6 | 0.32421346 |
| 170 | CDK7 | 0.32214871 |
| 171 | BMX | 0.31272356 |
| 172 | CSNK2A2 | 0.30969776 |
| 173 | PRKG2 | 0.30933751 |
| 174 | TIE1 | 0.30128746 |
| 175 | ZAK | 0.26641482 |
| 176 | TEC | 0.26576475 |
| 177 | MAPK3 | 0.26092834 |
| 178 | MST1R | 0.24344603 |
| 179 | ITK | 0.24255546 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Other glycan degradation_Homo sapiens_hsa00511 | 3.38476210 |
| 2 | Nicotine addiction_Homo sapiens_hsa05033 | 3.16922777 |
| 3 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 2.82630417 |
| 4 | GABAergic synapse_Homo sapiens_hsa04727 | 2.76038163 |
| 5 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 2.42359411 |
| 6 | Glutamatergic synapse_Homo sapiens_hsa04724 | 2.34139584 |
| 7 | Allograft rejection_Homo sapiens_hsa05330 | 2.32672471 |
| 8 | Lysosome_Homo sapiens_hsa04142 | 2.30836775 |
| 9 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 2.30700530 |
| 10 | Circadian entrainment_Homo sapiens_hsa04713 | 2.30433654 |
| 11 | Olfactory transduction_Homo sapiens_hsa04740 | 2.29895231 |
| 12 | Morphine addiction_Homo sapiens_hsa05032 | 2.28275925 |
| 13 | Asthma_Homo sapiens_hsa05310 | 2.16815413 |
| 14 | Long-term potentiation_Homo sapiens_hsa04720 | 2.13665839 |
| 15 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 2.07254755 |
| 16 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 2.06925069 |
| 17 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 2.05544029 |
| 18 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 2.03224686 |
| 19 | Proteasome_Homo sapiens_hsa03050 | 2.03172560 |
| 20 | Primary immunodeficiency_Homo sapiens_hsa05340 | 2.00926027 |
| 21 | Amphetamine addiction_Homo sapiens_hsa05031 | 1.99385258 |
| 22 | Dopaminergic synapse_Homo sapiens_hsa04728 | 1.98763414 |
| 23 | Graft-versus-host disease_Homo sapiens_hsa05332 | 1.91066780 |
| 24 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 1.89834130 |
| 25 | Salivary secretion_Homo sapiens_hsa04970 | 1.83778978 |
| 26 | Insulin secretion_Homo sapiens_hsa04911 | 1.83300543 |
| 27 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.81887092 |
| 28 | Sulfur relay system_Homo sapiens_hsa04122 | 1.73797842 |
| 29 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 1.72160212 |
| 30 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.71684003 |
| 31 | Gastric acid secretion_Homo sapiens_hsa04971 | 1.70378242 |
| 32 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 1.70320953 |
| 33 | Serotonergic synapse_Homo sapiens_hsa04726 | 1.68492762 |
| 34 | Cholinergic synapse_Homo sapiens_hsa04725 | 1.65986573 |
| 35 | Cocaine addiction_Homo sapiens_hsa05030 | 1.65213836 |
| 36 | Renin secretion_Homo sapiens_hsa04924 | 1.62898738 |
| 37 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.62240153 |
| 38 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 1.61021027 |
| 39 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 1.60558265 |
| 40 | Leishmaniasis_Homo sapiens_hsa05140 | 1.60163448 |
| 41 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 1.59906903 |
| 42 | Long-term depression_Homo sapiens_hsa04730 | 1.58566536 |
| 43 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 1.57529098 |
| 44 | Base excision repair_Homo sapiens_hsa03410 | 1.57215917 |
| 45 | Galactose metabolism_Homo sapiens_hsa00052 | 1.55295766 |
| 46 | Carbon metabolism_Homo sapiens_hsa01200 | 1.55006977 |
| 47 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.52136487 |
| 48 | DNA replication_Homo sapiens_hsa03030 | 1.50864723 |
| 49 | Taste transduction_Homo sapiens_hsa04742 | 1.50505333 |
| 50 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 1.50166975 |
| 51 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.49677025 |
| 52 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 1.48771608 |
| 53 | Parkinsons disease_Homo sapiens_hsa05012 | 1.46453890 |
| 54 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.46282841 |
| 55 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 1.46131442 |
| 56 | Glutathione metabolism_Homo sapiens_hsa00480 | 1.45965511 |
| 57 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 1.43736907 |
| 58 | Viral myocarditis_Homo sapiens_hsa05416 | 1.42210502 |
| 59 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 1.40677854 |
| 60 | Nitrogen metabolism_Homo sapiens_hsa00910 | 1.39577141 |
| 61 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 1.39243959 |
| 62 | Alzheimers disease_Homo sapiens_hsa05010 | 1.36462209 |
| 63 | Calcium signaling pathway_Homo sapiens_hsa04020 | 1.32556328 |
| 64 | Peroxisome_Homo sapiens_hsa04146 | 1.31500333 |
| 65 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.31098977 |
| 66 | GnRH signaling pathway_Homo sapiens_hsa04912 | 1.29774355 |
| 67 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 1.28556140 |
| 68 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.24355072 |
| 69 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.23104330 |
| 70 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.22983562 |
| 71 | One carbon pool by folate_Homo sapiens_hsa00670 | 1.22133243 |
| 72 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 1.20608953 |
| 73 | Gap junction_Homo sapiens_hsa04540 | 1.20512691 |
| 74 | Axon guidance_Homo sapiens_hsa04360 | 1.19075757 |
| 75 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 1.19069306 |
| 76 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 1.18747460 |
| 77 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.15800379 |
| 78 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.15671810 |
| 79 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 1.15342425 |
| 80 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 1.14259853 |
| 81 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.13095139 |
| 82 | Phototransduction_Homo sapiens_hsa04744 | 1.09671708 |
| 83 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.08260574 |
| 84 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 1.07678133 |
| 85 | cAMP signaling pathway_Homo sapiens_hsa04024 | 1.06690864 |
| 86 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.06467705 |
| 87 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.01451302 |
| 88 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.98883754 |
| 89 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.98482858 |
| 90 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.98440729 |
| 91 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.96251981 |
| 92 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.94759399 |
| 93 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.90909568 |
| 94 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.89088165 |
| 95 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.88955367 |
| 96 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.88436009 |
| 97 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.87797698 |
| 98 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.87717428 |
| 99 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.87524092 |
| 100 | Purine metabolism_Homo sapiens_hsa00230 | 0.86127269 |
| 101 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.82864748 |
| 102 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.82441731 |
| 103 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.81662279 |
| 104 | Salmonella infection_Homo sapiens_hsa05132 | 0.81479009 |
| 105 | Tuberculosis_Homo sapiens_hsa05152 | 0.81276763 |
| 106 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.81076521 |
| 107 | Phagosome_Homo sapiens_hsa04145 | 0.80539695 |
| 108 | Glioma_Homo sapiens_hsa05214 | 0.79167910 |
| 109 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.78681928 |
| 110 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.78354918 |
| 111 | Osteoclast differentiation_Homo sapiens_hsa04380 | 0.76695109 |
| 112 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.76616119 |
| 113 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.76203694 |
| 114 | Influenza A_Homo sapiens_hsa05164 | 0.75780790 |
| 115 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 0.75160134 |
| 116 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.73882446 |
| 117 | Bladder cancer_Homo sapiens_hsa05219 | 0.73452875 |
| 118 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.72833629 |
| 119 | Huntingtons disease_Homo sapiens_hsa05016 | 0.71737821 |
| 120 | Melanogenesis_Homo sapiens_hsa04916 | 0.71394740 |
| 121 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.70481534 |
| 122 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.69273432 |
| 123 | Bile secretion_Homo sapiens_hsa04976 | 0.67658794 |
| 124 | Fatty acid degradation_Homo sapiens_hsa00071 | 0.67150492 |
| 125 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.66134508 |
| 126 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.65993638 |
| 127 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.63722976 |
| 128 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.63627860 |
| 129 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.62142191 |
| 130 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 0.61259771 |
| 131 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.61100050 |
| 132 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.60969166 |
| 133 | Apoptosis_Homo sapiens_hsa04210 | 0.60327230 |
| 134 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.60308989 |
| 135 | Shigellosis_Homo sapiens_hsa05131 | 0.60094851 |
| 136 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.60072042 |
| 137 | Prion diseases_Homo sapiens_hsa05020 | 0.59057538 |
| 138 | Mismatch repair_Homo sapiens_hsa03430 | 0.58318441 |
| 139 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.57937490 |
| 140 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 0.57390322 |
| 141 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.56781861 |
| 142 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.56592754 |
| 143 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.56445788 |
| 144 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.56272570 |
| 145 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.56261664 |
| 146 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.56021664 |
| 147 | Metabolic pathways_Homo sapiens_hsa01100 | 0.54440027 |
| 148 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.53976830 |
| 149 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.53928329 |
| 150 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.53401416 |
| 151 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.53005849 |
| 152 | Non-homologous end-joining_Homo sapiens_hsa03450 | 0.51915010 |
| 153 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.51338191 |
| 154 | Malaria_Homo sapiens_hsa05144 | 0.50808187 |
| 155 | HTLV-I infection_Homo sapiens_hsa05166 | 0.49788095 |
| 156 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.48908205 |
| 157 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.48564401 |
| 158 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.47999066 |
| 159 | Homologous recombination_Homo sapiens_hsa03440 | 0.46964442 |
| 160 | Legionellosis_Homo sapiens_hsa05134 | 0.46503756 |
| 161 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.46360952 |
| 162 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.45888483 |
| 163 | Measles_Homo sapiens_hsa05162 | 0.45823925 |
| 164 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.45169499 |
| 165 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 0.45161796 |
| 166 | Pertussis_Homo sapiens_hsa05133 | 0.44878964 |
| 167 | Ribosome_Homo sapiens_hsa03010 | 0.43938797 |
| 168 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.43563131 |
| 169 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.43513346 |
| 170 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.43406230 |
| 171 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.42518578 |
| 172 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.40644033 |
| 173 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.40462742 |
| 174 | Propanoate metabolism_Homo sapiens_hsa00640 | 0.39960234 |
| 175 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.39564222 |
| 176 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.37753298 |
| 177 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 0.35681897 |
| 178 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.35462846 |
| 179 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.33680155 |
| 180 | Alcoholism_Homo sapiens_hsa05034 | 0.33523144 |
| 181 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.33258237 |
| 182 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.33104224 |
| 183 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.32344954 |
| 184 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.31896036 |
| 185 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.30617328 |

